Associated Partners (APs)

Stacks Image 8507
Eight Associated Partners (APs) provide expert advice, training and hands-on experience in applied aspects of biocatalysis, flow chemistry, electrochemistry including computational aspects, and sustainable synthesis. During their second year of research, ESRs participated in 1-2 month secondments at:

CLEA Technologies BV, Netherlands
Professor Roger Sheldon

CLEA Technologies BV, based in Delft, has broad experience in immobilising enzymes and developing cost-effective, green biocatalytic processes. The Sheldon Group has over 25 years experience in green and sustainable chemistry.

Gensoric GmbH, Germany
Dr. Gerd-Uwe Flechsig (based at UAlbany - SUNY, US), Jürgen Blume and Lars Krüger

Gensoric is a leading provider of novel and innovative solutions in electrochemistry with their currently unique technology of directly heated electrodes. Besides enhancing electrochemical analytical methods, Gensoric’s technology also opens up new ways in synthesis, biocatalysis, and process engineering.

Institute of Microelectronics Barcelona, Spain
Dr. F. Javier del Campo and Dr. César Fernández-Sánchez
IMB-CNM is the largest public microelectronics research and development centre in Spain. IMB's experience and expertise is in micro-/nanofabrication, analytical electrochemistry and development of lab-on-chip devices integrating electrochemical transducers.

Latvian Institute of Organic Synthesis, Latvia
Dr. Peteris Trapencieris

LIOS is an organic chemistry, molecular biology and bioorganic chemistry research institute based in Riga. Since it was established in 1957 it has brought around 17 drugs to market and over 70 patented methods for generic drug production.

Novartis Institutes for Biomedical Research, Switzerland
Dr. Martin Eberle

NIBR is the global pharmaceutical research organisation for Novartis with 10 research centres in nine locations across Europe, Asia and the United States. It employs over 6,000 scientists, physicians and business professionals. A team of specialist researchers including Drs. Richard Robinson, Fabrice Gallou, Andreas Fredenhagen and Stephan Luetz will be supporting OxIOSCR ESRs with their expertise and experience in electrochemistry, flow chemistry, medicinal chemistry and biocatalysis.

Prous Institute of Biomedical Research, Spain
Dr. David Prous and Dr. Josep Prous, Jr.

Prous Institute for Biomedical research is a drug discovery company based in Barcelona. The company, founded in 2000 as a spin-off of Prous Science (acquired by Thomson reuters in 2007), is committed to the discovery of novel therapies for unmet medical needs through the application of proprietary computational tools and methods and its expertise in knowledge management, computational sciences, synthetic chemistry, molecular and cellular biology and pharmacology.

Delft University of Technology/Department of Biotechnology, Netherlands
Professor Isabel Arends & Dr. Frank Hollmann
The Biocatalysis and Organic Chemistry group, at the Delft University of Technology, carries out research towards the development of atom-efficient, low-waste processes for the synthesis of high added value chemicals including pharmaceuticals and chiral intermediates. Within the framework of green chemistry, the group uses biocatalytic and biomimetic catalytic methods to achieve selectivity and waste minimisation.

Associated Partner-led training in sustainable and industrial scale-up processes:

Sorso Ltd, UK
Dr. Gareth DeBoos
Sorso Ltd is a UK-based consultancy business with marketing, business development, operations and process technology expertise in the biotechnology and healthcare sectors. Sorso's consultants and associates have extensive links to the European biotechnology industry and clean technology innovators.